U.S. Markets closed

Today's Research Reports on Trending Tickers: Novavax and Applied Genetic Technologies

NEW YORK, NY / ACCESSWIRE / December 13, 2018 / U.S. equities closed higher on Wednesday amidst renewed hopes over the U.S.-China trade talks. According to a report in Wall Street Journal, China is working on a plan to expand their access to foreign companies that will support the U.S.-China trade relations, and will replace the Made in China 2025 plan. The Dow Jones Industrial Average gained 0.64 percent to close at 24,527.27, while the S&P 500 Index increased 0.54 percent to close at 2,651.07. The Nasdaq Composite Index climbed 0.95 percent to close at 7,098.31.

The Market Edge Initiates Coverage on:

Novavax, Inc.
https://marketedgereport.com/report/NVAX/

Applied Genetic Technologies Corporation
https://marketedgereport.com/report/AGTC/

Novavax's stock jumped 11.21% Wednesday, to close the day at $2.48. The stock recorded a trading volume of 17,263,454 shares, which was above its three months average volume of 6,833,292 shares. In the last year, Novavax's shares have traded in a range of 1.05 - 2.75. The share price has gained 136.19% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.87 is above its 200-day moving average of $1.62. Shares of Novavax have gained roughly 45.03 percent in the past month and are up 100 percent year-to-date.

Access The Market Edge's Novavax, Inc. Research Report:
https://marketedgereport.com/report/NVAX/

On Wednesday, shares of Applied Genetic Technologies recorded a trading volume of 347,527 shares, which was above the three months average volume of 167,030 shares. The stock ended the day 7.36% higher at $6.56. The share price has fallen 12.53% from its 52 week high with a 52 week trading range of 3.25 - 7.50. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $5.67 is above its 200-day moving average of $4.79. Shares of Applied Genetic Technologies have fallen roughly 6.95 percent in the past month and are up 82.22 percent year-to-date.

Access The Market Edge's Applied Genetic Technologies Corporation Research Report:
https://marketedgereport.com/report/AGTC/

Our Actionable Research on Novavax, Inc. (NASDAQ : NVAX ) and Applied Genetic Technologies Corporation (NYSE : AGTC ) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: The Market Edge